Ascendis Pharma A/S (ASND) — Earnings Call Analysis & IR Page

Ascendis Pharma A/S is a Healthcare company operating in Biotechnology with a $17.27B market cap.

Most recent earnings call: Q1 FY26 on May 7, 2026.

21 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.80

investors.ascendispharma.com

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 21 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ASND.

$ curl https://api.spokenalpha.com/v1/companies/ASND

Get an API key API docs

FAQ

Frequently asked about ASND

Where can I find Ascendis Pharma A/S's (ASND) earnings call transcripts?

Spoken Alpha indexes ASND's earnings call transcripts at https://spokenalpha.com/companies/ASND. Each call links to attributed speakers and parsed analyst Q&A. Ascendis Pharma A/S's own investor relations page is at https://investors.ascendispharma.com/.

When was Ascendis Pharma A/S's most recent earnings call?

Ascendis Pharma A/S (ASND) held its most recent earnings call on 2026-05-07, covering fiscal Q1 2026.

What sector is ASND in?

Ascendis Pharma A/S (ASND) operates in the Healthcare sector (Biotechnology industry).

Overview